Centenaire Biosciences

Developer of antibody therapies to treat cancer and immune diseases

placeSuwon-si, Gyeonggi-do, South Korea calendar_todayFounded 2021 language koreabiomed.com

Social engagement

Social engagement: 8.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%

Recent activity

2 Jul 2026
Partnership
oversee
2 Jul 2026
Product launch
Larazepam Injection
2 Jul 2026
Milestone
regulatory
Coming soon